VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
GNW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
GNWGenworth Financial, Inc.
$9.55$3.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGNWCash Flow

Genworth Financial, Inc. (GNW) Cash Flow Statement

24Y historyFree accessUpdated daily

Operating cash flow of $52M in Q2 2026 exceeded net income of $47M, reflecting an OCF/NI ratio of 1.11, while buybacks of $45M were fully funded by cash generation.

Income StatementBalance SheetCash FlowRatios

GNW Cash Flow Statement

Annual statement

GNW Cash Flow Statement

Genworth Financial, Inc. (GNW) cash flow statement — 24-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02
Cash from Operations430M327M88M597M1.05B437M1.96B2.08B1.63B2.55B1.85B1.59B2.44B1.4B962M3.13B1.34B1.93B5.44B4.79B4.37B3.48B5.5B3.72B4.88B
Operating CF Growth %1529.09%271.59%-85.26%-43.09%140.05%-77.7%-5.72%27.31%-36.06%37.91%16.4%-34.74%74.27%45.43%-69.22%133.91%-30.81%-64.52%13.61%9.76%25.47%-36.72%47.95%-23.9%-
Operating CF / Revenue %6.15%5.14%1.23%8.1%14.18%5.75%23.87%26.98%20.7%33.99%22.15%18.61%27.93%16.22%9.98%31.49%13.24%21.29%54.71%43.07%42.44%35.55%53.03%33.79%43.49%
Net Income212M350M4M76M1.05B864M761M519M297M936M-38M-6M-1.05B726M523M261M285M-399M-572M1.15B62M105M1.15B-863M-526M
Depreciation & Amortization85M93M130M40M00-570M557M269M288M360M546M1.08B61M639M743M756M782M884M802M745M853M1.24B1.35B1.22B
Stock-Based Compensation68M58M51M49M37M40M39M27M37M42M32M16M30M41M26M31M44M26M23M41M49M0000
Deferred Taxes-31M-55M-103M48M315M275M268M139M5M-368M145M-196M-487M-79M88M-309M-294M-476M-430M252M368M891M-1.2B-63M-55M
Other Non-Cash Items-971M-925M-618M-933M-884M-1.76B-646M-699M-883M-363M-321M-788M-777M-812M-1.17B14M-1.36B-87M1.75B-1.66B-418M-329M-1.36B-177M-376M
Working Capital Changes953M806M624M1.32B535M1.01B2.11B1.54B1.91B2.02B1.67B2.02B3.64B1.46B854M2.38B1.9B2.08B3.79B4.2B3.56B1.96B5.67B3.47B4.62B
Cash from Investing181M518M861M1.26B733M896M-1.15B1.3B-622M-759M-2.12B-404M-1.84B-580M-722M-59M-1.81B820M1.97B-1.88B-2.9B-3.28B-5.4B-681M-6.53B
Capital Expenditures000000267M00000000000463M000000
Acquisitions-98M-334M-274M-384M-460M-242M-267M1.4B0-5M39M273M0365M46M207M-37M-51M-22M-31M-511M01M1.59B-61M
Purchase of Investments-2.68B-4.33B-4.45B-3.23B-4.04B-5.22B-9.84B-7.29B-10.71B-9.59B-11.68B-9.75B-9.53B-10.8B-12.33B-12.41B-13.24B-10.18B-6.98B-16.89B-16.78B-13.25B-16.86B-29.5B-35.41B
Sale/Maturity of Investments1.3B5.02B5.19B4.66B5.39B6.45B8.29B7.32B10.35B8.99B9.52B9.11B7.85B9.56B11.33B11.52B10.81B10.62B9.73B15.16B7.34B7.05B16.67B26.65B28.88B
Other Investing1.65B160M392M215M-158M-99M387M-128M-266M-157M6M-34M-158M295M237M629M648M431M-1.23B-112M7.05B2.92B-5.21B583M62M
Cash from Financing-422M-857M-1.11B-1.44B-1.55B-2.42B-1.51B-2.22B-1.62B-1.77B-2.93B-42M205M-149M-1.1B-1.64B-1.51B-5.31B-2.91B-2.29B-835M-248M-791M-2.71B2.29B
Dividends Paid00-21M0000-87M-97M-107M-138M00-535M-50M-67M-43M-10M-175M-163M-145M-128M-1.61B-3.23B0
Share Repurchases-324M-319M-189M-296M-64M00-22M0-33M00000000-76M-1.12B-1B-500M000
Stock Issued00000529M022M000226M517M0000622M0600M001.91B261M0
Debt Issuance (Net)-3M-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K1000K-1000K-1000K1000K-1000K1000K-1000K1000K1000K-1000K1000K-1000K
Other Financing-76M-531M-831M-1.11B-1.19B-1.41B-1.44B-1.68B-1.42B-1.73B-927M25M239M-389M-12M-1.13B-2.47B770M-3.91B-1.41B-335M-61M753M-132M2.37B
Net Change in Cash189M-12M-167M416M228M-1.08B-685M1.16B-698M91M-3.21B1.05B704M561M-835M1.36B-1.87B-2.33B4.24B622M594M-88M-590M413M688M
Exchange Rate Effect00-1M1M01M15M1M-88M64M-10M-70M-103M-109M26M-69M121M232M-258M6M-38M-42M107M92M37M
Cash at Beginning2.12B2.05B2.21B1.8B1.57B2.66B3.34B2.18B2.88B2.78B5.99B4.92B4.21B3.65B4.49B3.13B5B7.33B3.09B2.47B1.88B1.96B1.98B1.57B881M
Cash at End1.99B2.04B2.05B2.21B1.8B1.57B2.66B3.34B2.18B2.88B2.78B5.96B4.92B4.21B3.65B4.49B3.13B5B7.33B3.09B2.47B1.88B1.39B1.98B1.57B
Free Cash Flow430M327M88M597M1.05B437M2.23B2.08B1.63B2.55B1.85B1.59B2.44B1.4B962M3.13B1.34B1.93B5.91B4.79B4.37B3.48B5.5B3.72B4.88B
FCF Growth %88.6%271.59%-85.26%-43.09%140.05%-80.38%7.12%27.31%-36.06%37.91%16.4%-34.74%74.27%45.43%-69.22%133.91%-30.81%-67.3%23.27%9.76%25.47%-36.72%47.95%-23.9%-
FCF Margin %6.15%5.14%1.23%8.1%14.18%5.75%27.12%26.98%20.7%33.99%22.15%18.61%27.93%16.22%9.98%31.49%13.24%21.29%59.37%43.07%42.44%35.55%53.03%33.79%43.49%
FCF per Share1.110.790.21.262.050.854.354.083.265.093.723.24.912.811.956.332.714.2813.6310.79.37.1811.217.5910.05

Key Metrics

Growth RegimeContracting
ProfitabilityStable
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Legacy LTC reserve volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Underwriting Cash Generation Stabilizes

Genworth's operating cash flow averaged $75.8 million per quarter over the last five quarters, with Q2 2026 at $52 million, indicating stable underwriting cash generation despite revenue contraction, as per recent SEC filings.

The operating cash flow to net income ratio has been volatile, ranging from 0.12 to 100, but the recent quarters show a more consistent pattern, with Q2 2026 at 1.11. This suggests that cash generation is aligning with reported earnings, though the underlying revenue decline of 10.9% YoY may pressure future cash flows. The stability in OCF appears to be supported by disciplined claims management and premium collections, but investors should monitor whether this can persist as legacy blocks run off.

Claims Payments Reflect Legacy Runoff

Claims and loss payments have declined from $1.7 billion in Q3 2025 to $1.2 billion in Q1 2026, a 29% reduction, suggesting a tapering of legacy LTC claims, as reported in the cash flow statement.

The reduction in claims payments may indicate that the company is experiencing favorable claims development, possibly due to policy lapses or improved morbidity assumptions. However, the persistence of medical cost inflation could reverse this trend, and the company's ability to secure premium rate increases will be critical. The declining claims payments, if sustained, could improve underwriting cash flow, but the absence of forward guidance limits visibility.

Portfolio Rotation Supports Liquidity

Investment purchases and sales have been substantial, with Q2 2026 showing $318 million in purchases and $2.3 billion in sales, indicating active portfolio management to fund operations and capital returns, based on reported figures.

The net sales of investments in Q2 2026 (approximately $2 billion) suggest that Genworth is liquidating a portion of its investment portfolio to support cash needs, possibly for debt reduction or share buybacks. This may indicate a strategic shift towards more liquid assets, but it also raises questions about the sustainability of investment income if the portfolio is being reduced. The company's large cash position of $2.036 billion provides a buffer, but the reliance on portfolio sales to generate cash may not be sustainable long-term.

Buybacks Funded by Cash Generation

Genworth repurchased $45 million of shares in Q2 2026, funded by operating cash flow of $52 million, indicating that buybacks are covered by cash generation, as per the latest quarterly statement.

The buyback activity, while modest, appears to be supported by operating cash flow, which is a positive sign for capital return sustainability. However, the company also sold investments to fund these repurchases, suggesting that cash generation alone may not be sufficient. The lack of dividends and the focus on buybacks may indicate management's confidence in the underlying cash flow, but the overall revenue decline warrants caution.

Earnings Quality Supported by Cash Conversion

Operating cash flow exceeded net income in Q2 2026 ($52 million vs $47 million), with a cumulative OCF/NI ratio of 1.11, indicating that reported earnings are backed by cash, as reported in financial statements.

The positive cash conversion suggests that earnings are not solely reliant on non-cash accruals, which is reassuring given the complexity of LDTI accounting. However, the volatility in OCF/NI across quarters (ranging from -0.77 to 100) indicates that earnings quality can fluctuate significantly. The Q2 2026 beat may be supported by favorable reserve developments, but the absence of forward guidance makes it difficult to assess the sustainability of this cash generation.

Cash Flow Obscures Legacy Risks

Despite stable operating cash flow, the reliance on investment sales and declining revenue may obscure underlying legacy LTC risks, as the company's cash flow statement does not fully reflect future reserve needs, based on reported data.

The cash flow statement shows significant investment portfolio turnover, which may mask the true liquidity position if the portfolio is being depleted to fund operations. Additionally, the decline in claims payments could be temporary, and the company's exposure to medical cost inflation remains a key risk. Investors should monitor whether the company can maintain cash generation without further portfolio liquidation, as this could signal underlying stress in the legacy blocks.

GNW — Frequently Asked Questions

Quick answers to the most common questions about buying GNW stock.

How much cash does Genworth Financial, Inc. (GNW) generate from operations?

Genworth Financial, Inc. (GNW) generated $327.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Genworth Financial, Inc.'s free cash flow?

Genworth Financial, Inc. (GNW) generated $327.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Genworth Financial, Inc.'s capital expenditure (CapEx)?

Genworth Financial, Inc. (GNW) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Genworth Financial, Inc. distribute cash to shareholders?

In 2025, Genworth Financial, Inc. (GNW) spent $319.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.